| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | Director | Common Stock | 29.5K | $2.56M | $86.65 | Jun 14, 2024 | Direct |
| Immunome Inc. | Director | Stock Option (Right to Buy) | 6.5K | Jun 8, 2023 | Direct | ||
| LIGAND PHARMACEUTICALS INC | Director | Non-Qualified Stock Option (right to buy) | 5.44K | Jun 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Jun 14, 2024 | 2 | $0 | 4 | Jun 18, 2024 | Director |
| LGND | LIGAND PHARMACEUTICALS INC | Jun 9, 2023 | 2 | $0 | 4 | Jun 13, 2023 | Director |
| IMNM | Immunome Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| IMNM | Immunome Inc. | Jan 15, 2023 | 1 | $60.5K | 4 | Jan 17, 2023 | Director |
| LGND | LIGAND PHARMACEUTICALS INC | Dec 22, 2022 | 1 | $0 | 4 | Dec 27, 2022 | Director |
| IMNM | Immunome Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| LGND | LIGAND PHARMACEUTICALS INC | Jun 10, 2022 | 2 | $0 | 4 | Jun 13, 2022 | Director |
| LGND | LIGAND PHARMACEUTICALS INC | Nov 16, 2021 | 3 | -$626K | 4 | Nov 17, 2021 | Director |
| LGND | LIGAND PHARMACEUTICALS INC | Jun 4, 2021 | 2 | $0 | 4 | Jun 7, 2021 | Director |
| IMNM | Immunome Inc. | May 28, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |
| IMNM | Immunome Inc. | May 24, 2021 | 2 | $101K | 4 | May 26, 2021 | Director |